Human skin-derived ABCB5+ mesenchymal stem cell injection improves liver disease parameters in Mdr2ko mice
V Hartwig(Heidelberg University), Steven Dooley(Heidelberg University), Anne Dropmann(University Hospital Heidelberg), Bruno Christ(Fraunhofer Institute for Silicate Research), Bedair Dewidar(Tanta University), Andreas Kluth(Rheacell (Germany)), Tao Lin(Shanghai Academy of Agricultural Sciences), Nils Tappenbeck(Rheacell (Germany))
Cited by 0
Related Papers
<scp>TGF</scp>‐β signalling and liver disease
|FEBS Journal|2016|611
Hepatocyte-Specific Smad7 Expression Attenuates TGF-β–Mediated Fibrogenesis and Protects Against Liver Damage
|Gastroenterology|2008|272
Present status and perspectives of cell-based therapies for liver diseases
|Journal of Hepatology|2006|205
Metabolic liver disease in diabetes – From mechanisms to clinical trials
|Metabolism|2020|156